×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [23]
上海药物研究所 [8]
复旦大学上海医学院 [7]
四川大学 [4]
上海生物化学与细胞生... [4]
武汉大学 [3]
更多...
内容类型
期刊论文 [60]
学位论文 [7]
会议论文 [3]
专利 [1]
发表日期
2022 [1]
2020 [1]
2019 [4]
2018 [11]
2017 [7]
2016 [11]
更多...
学科主题
Oncology [3]
Science & ... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共71条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17
作者:
Xu, X.
;
Li, N.
;
Fan, Y.
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2022/12/23
ALK
non-small cell lung cancer (NSCLC)
leptomeningeal metastases (LM)
Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function
期刊论文
MOLECULAR CANCER THERAPEUTICS, 2020, 卷号: 19, 期号: 11, 页码: 2340-2352
作者:
Jin, Rui
;
Liu, Liang
;
Xing, Yun
;
Meng, Tao
;
Ma, Lanping
收藏
  |  
浏览/下载:49/0
  |  
提交时间:2020/12/24
Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients
期刊论文
DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 卷号: 13
作者:
Zhang, Tengfei
;
Zhang, Lu
;
Xie, Yuancai
;
Li, Bing
;
Ma, Yafeng
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2019/12/05
EGFR alteration
ALK rearrangement
nonsmall cell lung cancer
EML4-ALK
tyrosine kinase inhibitor
Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients
期刊论文
Drug Design, Development and Therapy, 2019, 卷号: 13, 页码: 1809-1817
作者:
Liu, Jixian
;
Mu, Zhimin
;
Liu, Li
;
Li, Kang
;
Jiang, Richeng
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2019/12/03
ALK rearrangement
EGFR alteration
EML4-ALK
Nonsmall cell lung cancer
Tyrosine kinase inhibitor
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib
期刊论文
2019, 卷号: 11, 页码: 8191-8200
作者:
Liang Hongge
;
Ma Di
;
Xu Yan
;
Zhao Jing
;
Chen Minjiang
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2020/01/03
crizotinib
echinoderm microtubule-associated protein-like 4–anaplastic lymphoma kinase
lactate dehydrogenase
non-small cell lung cancer
progression-free survival
Refinement of diagnosis and supporting evidence for the use of immunotherapy through sequential biopsies in a case of EML4-ALK positive lung cancer
期刊论文
2019, 卷号: 12, 页码: 2943-2948
作者:
Song, Peng
;
Zhang, Jingcheng
;
Zhang, Li
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
sequential biopsies
EML4-ALK
immunotherapy
lung adenocarcinoma
Design, synthesis and pharmacological evaluation of ALK and Hsp90 dual inhibitors bearing resorcinol and 2,4-diaminopyrimidine motifs
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 152, 页码: 76-86
作者:
Geng, Kaijun
;
Liu, Hongchun
;
Song, Zilan
;
Zhang, Chi
;
Zhang, Minmin
收藏
  |  
浏览/下载:172/0
  |  
提交时间:2019/01/08
Heat shock protein 90 (Hsp90)
Tyrosine kinase ALK
Dual inhibitor
Drug resistance
Antiproliferative activity
EML4-ALK fusion variants associate with gender and age in Chinese NSCLC patients
期刊论文
ANNALS OF ONCOLOGY, 2018, 卷号: 29
作者:
Zhao, W.
;
Liang, G.
;
Wang, L.
;
Dai, L.
;
Wu, D.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/04
A Novel EML6-ALK FBXO11-ALK Double Fusion Variant in Lung Adenocarcinoma and Response to Crizotinib
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2018, 卷号: 13, 期号: 11
作者:
Lin, Hao
;
Ren, Guoqiang
;
Liang, Xiaohua
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma
期刊论文
MEDICINE, 2018, 卷号: 97
作者:
Wang, Hongyan
;
Zhang, Wen
;
Wang, Kai
;
Li, Xiaofeng
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/11/26
gene mutation
lung adenocarcinoma
EGFR
correlation analysis
EML4-ALK
©版权所有 ©2017 CSpace - Powered by
CSpace